Drugs Made In America Acquisition Corp. DMAA
$10.80
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.73M | 1.97M | 213.00K | 2.18M | 2.29M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.86M | -2.08M | -279.10K | -2.42M | -2.43M |
| Change in Net Operating Assets | -107.70K | 22.10K | -59.00K | 176.60K | 36.20K |
| Cash from Operations | -244.60K | -91.30K | -125.20K | -56.10K | -106.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.71M | -- | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 98.71M | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | 250.00K | 100.00K | -- | -- | -- |
| Total Debt Repaid | -99.31M | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | -- | -- | 130.60K | 56.00K | 106.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 600.00K | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -98.46M | 100.00K | 130.60K | 56.00K | 106.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.40K | 8.80K | 5.40K | -100.00 | -100.00 |